5.0
30. Sept. 2021
Aktueller Mitarbeiter, mehr als 1 Jahr
Sydney
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Company is the perfect size to be nimble and explorative. Staff are experienced throughout the drug development process. Senior management is well rounded, fair and knowledgeable
Kontras
Don't have any serious issues